An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL)
Year: 2018
Type: article
Authors: Peter Borchmann, Constantine S. Tam, U. Jaeger, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael Bishop, Charalambos Andreadis, S.R. Foley, Jason R. Westin, Isabelle Fleury, P. Joy Ho, Stephan Mielke, Gilles Salles, R. Maziarz, Oe Anak, Lida Pacaud, Christopher del Corral, R. Awasthi, Sergei Agoulnik, Feng Tai, S. J. Schuster
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3016890632